| Dr David Allen Brantley, MD | |
|
6060 Piedmont Row Dr S Fl 6, Charlotte, NC 28287 | |
| (704) 489-3094 | |
| Not Available |
| Full Name | Dr David Allen Brantley |
|---|---|
| Gender | Male |
| Speciality | Endocrinology |
| Experience | 28 Years |
| Location | 6060 Piedmont Row Dr S Fl 6, Charlotte, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790706182 | NPI | - | NPPES |
| N0019A | Medicaid | SC | |
| 1790706182 | Medicaid | NC | |
| 891211V | Medicaid | NC | |
| 1211V | Other | NC | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 9800197 (North Carolina) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Tryon Medical Partners, Pllc | 7113277971 | 119 |
News Archive
Precision BioSciences, Inc., today announced that the United States Patent and Trademark Office (PTO) has issued Final Decisions and Right of Appeal Notices in the reexamination proceedings for U.S. Pat. Nos. 6,833252, 7,214,536, 6,610,545 and 7,309,605 that are owned by the Institut Pasteur and the Universite Pierre et Marie Curie, and licensed to Cellectis, SA (ALCLS).
WMDO, the leading global provider of innovative online training for medical device professionals, and AusBiotech, Australia's leading biotechnology industry organization, announced today a strategic partnership that offers AusBiotech Members access to WMDO's professional online training.
"Senate Democrats may decide to pass a U.S. health-care overhaul without Republican support if some opposition lawmakers don't agree to a plan by mid-September," Senator Charles Schumer[ D-N.Y.] said" according to Bloomberg. Schumer said Sen. Max Baucus, D-Mont., set a self-imposed deadline of Sept. 15 to lead a negotiating team, composed of three Republicans and three Democrats within his Finance Committee, to a bipartisan compromise.
Researchers at the Dana-Farber Cancer Institute (Dana-Farber), Burnham Institute for Medical Research (Burnham) and the Centers for Disease Control and Prevention (CDC) have reported the identification of human monoclonal antibodies (mAb) that neutralize an unprecedented range of influenza A viruses, including avian influenza A (H5N1) virus, previous pandemic influenza viruses, and some seasonal influenza viruses.
› Verified 2 days ago
| Entity Name | Tryon Medical Partners, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992204549 PECOS PAC ID: 7113277971 Enrollment ID: O20180829002057 |
News Archive
Precision BioSciences, Inc., today announced that the United States Patent and Trademark Office (PTO) has issued Final Decisions and Right of Appeal Notices in the reexamination proceedings for U.S. Pat. Nos. 6,833252, 7,214,536, 6,610,545 and 7,309,605 that are owned by the Institut Pasteur and the Universite Pierre et Marie Curie, and licensed to Cellectis, SA (ALCLS).
WMDO, the leading global provider of innovative online training for medical device professionals, and AusBiotech, Australia's leading biotechnology industry organization, announced today a strategic partnership that offers AusBiotech Members access to WMDO's professional online training.
"Senate Democrats may decide to pass a U.S. health-care overhaul without Republican support if some opposition lawmakers don't agree to a plan by mid-September," Senator Charles Schumer[ D-N.Y.] said" according to Bloomberg. Schumer said Sen. Max Baucus, D-Mont., set a self-imposed deadline of Sept. 15 to lead a negotiating team, composed of three Republicans and three Democrats within his Finance Committee, to a bipartisan compromise.
Researchers at the Dana-Farber Cancer Institute (Dana-Farber), Burnham Institute for Medical Research (Burnham) and the Centers for Disease Control and Prevention (CDC) have reported the identification of human monoclonal antibodies (mAb) that neutralize an unprecedented range of influenza A viruses, including avian influenza A (H5N1) virus, previous pandemic influenza viruses, and some seasonal influenza viruses.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David Allen Brantley, MD 5960 Fairview Rd Ste 500, Charlotte, NC 28210-3113 Ph: (704) 495-6334 | Dr David Allen Brantley, MD 6060 Piedmont Row Dr S Fl 6, Charlotte, NC 28287 Ph: (704) 489-3094 |
News Archive
Precision BioSciences, Inc., today announced that the United States Patent and Trademark Office (PTO) has issued Final Decisions and Right of Appeal Notices in the reexamination proceedings for U.S. Pat. Nos. 6,833252, 7,214,536, 6,610,545 and 7,309,605 that are owned by the Institut Pasteur and the Universite Pierre et Marie Curie, and licensed to Cellectis, SA (ALCLS).
WMDO, the leading global provider of innovative online training for medical device professionals, and AusBiotech, Australia's leading biotechnology industry organization, announced today a strategic partnership that offers AusBiotech Members access to WMDO's professional online training.
"Senate Democrats may decide to pass a U.S. health-care overhaul without Republican support if some opposition lawmakers don't agree to a plan by mid-September," Senator Charles Schumer[ D-N.Y.] said" according to Bloomberg. Schumer said Sen. Max Baucus, D-Mont., set a self-imposed deadline of Sept. 15 to lead a negotiating team, composed of three Republicans and three Democrats within his Finance Committee, to a bipartisan compromise.
Researchers at the Dana-Farber Cancer Institute (Dana-Farber), Burnham Institute for Medical Research (Burnham) and the Centers for Disease Control and Prevention (CDC) have reported the identification of human monoclonal antibodies (mAb) that neutralize an unprecedented range of influenza A viruses, including avian influenza A (H5N1) virus, previous pandemic influenza viruses, and some seasonal influenza viruses.
› Verified 2 days ago
Dr. Anish Kaushik Vani, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 125 Queens Rd Ste 200, Charlotte, NC 28204 Phone: 704-343-9800 Fax: 704-347-2011 | |
John Michael Fedor, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1237 Harding Pl, Ste 3100, Charlotte, NC 28204 Phone: 704-373-0212 | |
Dr. Michael Warren Smith, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 6115 Park South Dr Ste 100, Charlotte, NC 28210 Phone: 704-554-8787 Fax: 704-554-8774 | |
William Lane Jr., MD Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 1350 S Kings Dr, Charlotte, NC 28207 Phone: 704-446-4490 | |
Dr. Alagusivakumari Rameshbabu, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 10648 Park Rd, Charlotte, NC 28210 Phone: 704-667-8050 | |
Shibin Thomas Jacob, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 101 E W T Harris Blvd, Bldg 5000 Suite #5101, Charlotte, NC 28262 Phone: 704-863-5847 | |
Oscar Sven Brann, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 6060 Piedmont Row Dr S Fl 10, Charlotte, NC 28287 Phone: 704-489-3094 |